Faculty Investigators

Richard M. Myers, Ph.D.

President, Director and Faculty Investigator, HudsonAlpha Institute

Richard Myers joined HudsonAlpha in 2008 from Stanford University, where he was Professor and Chair of the Department of Genetics and Director of the Stanford Human Genome Center. Dr. Myers received his graduate training at University of California Berkeley and carried out his postdoctoral training at Harvard University.

Devin Absher, Ph.D.

Faculty Investigator


Devin Absher joined HudsonAlpha in 2010 from Stanford University, where he was a senior scientist at the Stanford Human Genome Center. Dr. Absher received his graduate degree in Genetics from Emory University and carried out postdoctoral training at Stanford University.

Jane Grimwood, Ph.D.

Faculty Investigator

Jane Grimwood received her B.Sc. and Ph.D. in microbiology from the University of Leeds in the United Kingdom, followed by postdoctoral training at the University of Oxford, Dartmouth College, and the University of San Francisco. In 2000, Dr.Grimwood became a senior scientist at the Stanford Human Genome Center where she and her group were responsible for finishing and performing quality analysis on 320 million base pairs of human chromosomes 5, 16 and 19, which compromise more than 10 percent of the human genome. In 2008, after the completion of the Human Genome Project, Dr.Grimwood joined HudsonAlpha to lead the Genome Sequencing Center, a group focused on sequencing, finishing and improving a wide variety of eukaryotic genomes, including plants, fungi and vertebrates. 

Neil Lamb, Ph.D.

Faculty Investigator

Neil Lamb joined HudsonAlpha in 2007 and serves as the director of educational outreach. Dr. Lamb received his graduate training at Emory University, where he was a faculty member in the Department of Human Genetics and the leader of educational outreach.

Douglas T. Ross, M.D., Ph.D.

Visiting Investigator

Douglas T. Ross is chief scientific officer and co-founder of Applied Genomics Inc. He obtained his M.D. and Ph.D. in pathology from the University of Washington in 1994 while studying at the Fred Hutchinson Cancer Research Center and did pathology training including serving as chief resident of laboratory medicine at the University of California at San Francisco. For his postdoctoral fellowship, he joined the then-emerging microarray project at Stanford University. As part of the team that initiated and scaled-up the human cDNA microarray gene expression profiling project he helped develop strategies for large-scale analysis of gene expression in human cancer. Ross then co-founded Applied Genomics Inc., one of the HudsonAlpha resident associate companies. AGI developed a process whereby complex gene expression data is used to target antibody production and generate datasets of protein expression across thousands of tumor tissues. The company is using these reagents and datasets to reveal a novel approach towards classification of cancer with great potential to account for the clinical variation among patients that clinicians have observed for decades.